|
Big pharmaceutical companies are paying the same key opinion leaders for many different services. All at the same time. And firms don't notice it because KOLs are Hidden in Silos
Oct 1, 2005
By:
Kashif Chaudhry, Anne Love
Data suggest that pharma companies engage the same key opinion leaders on assignments in three to seven departments or product groups at once.
|
In the old days, pills were products. Today, marketers need to treat them as time-sensitive opportunities. If you don't, you'll be left at the gate.
Feb 1, 2005
By:
Kashif Chaudhry, Jaime Cyr
The inclusion of pharmacoeconomic endpoints in Phase III clinical trials presents a stronger package in support of a US product launch.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
